3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Liver Failure
1
Hepatitis C
1
Hepatitis B
1
Hepatic Insufficiency
1
HIV Infections
1
Carcinoma, Hepatocellular
1
Interventions
Specimen Handling
4
Magnetic Resonance Spectroscopy
4
Nivolumab
3
Watchful Waiting
2
Light Coagulation
2
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
2
Fluorouracil
2
Biopsy
2
pembrolizumab
1
dehydroftorafur
1
cabozantinib
1
Vorinostat
1
Taxes
1
Sigmoidoscopy
1
Sentinel Lymph Node Biopsy
1
Raltegravir Potassium
1
Radiotherapy, Intensity-Modulated
1
Proctoscopy
1
Papanicolaou Test
1
Paclitaxel
1
Observation
1
Mitozytrex
1
Mitomycin
1
Mass Screening
1
Laser Therapy
1
Isotretinoin
1
Ipilimumab
1
Interferon alpha-2
1
Imiquimod
1
Fluorodeoxyglucose F18
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
HIV Infections
×
Raltegravir Potassium
×
Gastrointestinal
×
Clear all
NCT01022476
2026-04-06
LIVERAL
ANRS, Emerging Infectious Diseases
Phase 1/2
Completed
14 enrolled